73.04
前日終値:
$73.70
開ける:
$73.7
24時間の取引高:
1.15M
Relative Volume:
0.87
時価総額:
$8.38B
収益:
$13.18B
当期純損益:
$419.00M
株価収益率:
22.33
EPS:
3.2704
ネットキャッシュフロー:
$521.00M
1週間 パフォーマンス:
-1.63%
1か月 パフォーマンス:
-11.35%
6か月 パフォーマンス:
+11.34%
1年 パフォーマンス:
+5.75%
Henry Schein Inc Stock (HSIC) Company Profile
Compare HSIC vs MCK, COR, CAH, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
HSIC
Henry Schein Inc
|
73.04 | 8.45B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
MCK
Mckesson Corporation
|
872.32 | 106.00B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
317.66 | 61.11B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
212.02 | 49.72B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
AHG
Akso Health Group Adr
|
2.32 | 1.95B | 14.85M | -136.07M | 7.23M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-08-26 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-25 | ダウングレード | Stifel | Buy → Hold |
| 2025-07-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | 開始されました | Wells Fargo | Equal Weight |
| 2025-01-06 | アップグレード | BofA Securities | Underperform → Buy |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-07-22 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2023-12-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-11-10 | アップグレード | Stifel | Hold → Buy |
| 2022-08-08 | アップグレード | UBS | Sell → Neutral |
| 2022-07-21 | ダウングレード | Goldman | Buy → Neutral |
| 2022-06-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | 再開されました | Credit Suisse | Outperform |
| 2022-01-31 | 開始されました | Morgan Stanley | Underweight |
| 2022-01-07 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | 再開されました | Credit Suisse | Neutral |
| 2021-02-08 | 再開されました | Piper Sandler | Overweight |
| 2021-01-04 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | アップグレード | Goldman | Neutral → Buy |
| 2020-04-02 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | アップグレード | Evercore ISI | Underperform → In-line |
| 2019-08-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | 開始されました | Wolfe Research | Underperform |
| 2019-05-15 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | 開始されました | Guggenheim | Buy |
| 2019-01-17 | 開始されました | UBS | Sell |
| 2019-01-03 | ダウングレード | Evercore ISI | In-line → Underperform |
| 2019-01-02 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | 繰り返されました | Barrington Research | Outperform |
| 2018-10-25 | ダウングレード | Edward Jones | Hold → Sell |
| 2018-10-19 | 再開されました | Goldman | Neutral |
| 2018-10-04 | 繰り返されました | Robert W. Baird | Outperform |
| 2018-08-07 | 繰り返されました | Stifel | Hold |
| 2018-04-24 | ダウングレード | Goldman | Buy → Neutral |
| 2018-04-04 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
すべてを表示
Henry Schein Inc (HSIC) 最新ニュース
Henry Schein Inc. stock rises Tuesday, still underperforms market - MarketWatch
Henry Schein Inc Stock: A Steady Force in Dental and Medical Distribution for North American Investo - AD HOC NEWS
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC), Encompass Health (EHC) and Merck & Company (MRK) - The Globe and Mail
Henry Schein (HSIC) down 9.4% since last earnings report: Can it rebound? - MSN
Henry Schein: A Cash-Generating Healthcare Distributor Priced for Mediocrity - TradingView
Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Update - MarketBeat
Assenagon Asset Management S.A. Buys 45,701 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein stock drops 2.18% as company recognized among World’s Most Ethical Companies - Traders Union
Henry Schein Inc Stock: A Steady Force in Dental and Medical Distribution for Long-Term Investors - AD HOC NEWS
Henry Schein (HSIC) price target increased by 12.37% to 90.80 - MSN
Henry Schein stock hits 52-week highhere's why - msn.com
Henry Schein Inc. stock underperforms Friday when compared to competitors - MarketWatch
Vanguard Reports 0 Shares in Henry Schein After Realignment (NASDAQ: HSIC) - Stock Titan
Henry Schein One Drives Growth with Cloud-Based Dental Solutions and AI Integration - Bitget
Henry Schein (HSIC) Down 9.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Should You Keep Henry Schein Shares in Your Investment Portfolio at This Time? - Bitget
Should You Retain Henry Schein Stock in Your Portfolio for Now? - Yahoo Finance
How Investors May Respond To Henry Schein (HSIC) Strong Q4 Specialty Products-Driven Margin Expansion - Sahm
Henry Schein (HSIC) Goldman Sachs 45th Annual Global Healthcare Conference Summary - Quartr
How Surging Global Specialty Sales At Henry Schein (HSIC) Have Changed Its Investment Story - Yahoo Finance
Henry Schein, Inc. $HSIC Shares Purchased by SG Americas Securities LLC - MarketBeat
Henry Schein, Vir Biotechnology, Ultra Clean Holdings and other big stocks moving higher on Tuesday - MSN
Henry Schein stock faces uncertain trading amid lack of fresh catalysts in dental distribution secto - AD HOC NEWS
Is Henry Schein Stock Underperforming the S&P 500? - Barchart
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
This Henry Schein analyst turns bullish; here are top 3 upgrades for Monday - MSN
Push Button Handpiece Conversion Midwest 380420 Low Speed AdapterHenry Schein Dental Push Button Starter Kit - hotelier.com.py
Tudor Investment Corp ET AL Invests $15.38 Million in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Q4 2025 earnings preview - MSN
Decliners Report: Will Henry Schein Inc face regulatory challengesWeekly Market Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn
Barclays Sticks to Their Buy Rating for Henry Schein (HSIC) - The Globe and Mail
Top Henry Schein Executive Makes Notable Insider Stock Move - TipRanks
Henry Schein (NASDAQ:HSIC) CEO Thomas Popeck Sells 1,355 Shares - MarketBeat
Insider Sell: Thomas Popeck Sells Shares of Henry Schein Inc (HS - GuruFocus
Charisma 66000085 Universal CompositeHenry Schein Dental - hotelier.com.py
Henry Schein CEO Popeck sells $98,630 in stock - Investing.com
Henry Schein CEO Popeck sells $98,630 in stock By Investing.com - Investing.com Australia
Henry Schein (HSIC) products CEO sells 1,355 shares in open-market trade - Stock Titan
3M Scotchbond 7423 Etchant Etching GelHenry Schein Dental - hotelier.com.py
Here's why Henry Schein (HSIC) is a strong growth stock - MSN
HSIC (NASDAQ) Form 144: insiders list 144, 191, 1,020 shares tied to vesting - Stock Titan
Zacks Research Has Negative View of Henry Schein Q1 Earnings - MarketBeat
Here's why Henry Schein (HSIC) is a strong value stock - MSN
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein secures Ethisphere World Most Ethical Companies recognition for 15th consecutive year - Traders Union
Henry Schein Named Among World’s Most Ethical Companies - Dentistry Today
Ethisphere Names Henry Schein as One of the 2026 World's Most Ethical Companies(R) for 15th Consecutive Year - marketscreener.com
Here's Why Henry Schein (HSIC) is a Strong Growth Stock - Yahoo Finance
These analysts increase their forecasts on Henry Schein after upbeat Q4 results - MSN
NY-HENRY-SCHEIN-INC - Caledonian Record
Henry Schein Inc (HSIC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):